Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Intrathecal (injected into the spinal fluid) DepoCyt
Pacira Ireland Limited
Meningeal Neoplasms
1 trial -
Intrathecal morphine injection
Pacira Ireland Limited
Pain
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Fever
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Obesity
1 trial -
Intravenous Immunoglobulins, Human
The First People's Hospital of Lianyungang
Guillain-Barre Syndrome
1 trial -
Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation
Rhythm Pharmaceuticals Netherlands B.V.
Arrhythmias, Cardiac
1 trial -
Intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Pain
3 trials -
Intravitreal Aflibercept
Regeneron UK Limited
Diabetic Macular Edema
2 trials -
Intravitreal Aflibercept Injection
Regeneron UK Limited
Cystoid Macular Edema
1 trial -
Intravitreal Aflibercept Injection (IAI)
Regeneron UK Limited
Chorioretinal Vascular Disease
1 trial -
Intravitreal Aflibercept Injection (IAI)
Regeneron UK Limited
Age - Related Macular Degeneration (AMD)
1 trial -
Intravitreal Aflibercept Injection 2mg
Regeneron UK Limited
Neovascular Age-related Macular Degeneration
2 trials -
Intravitreal aflibercept injection
Regeneron UK Limited
Macular Degeneration
1 trial -
Investigational live attenuated varicella vaccine
Sinovac Research and Development Co.,
Varicella
4 trials -
Iohexol 300 mg I/ml solution for injection, MORPHINE (CHLORHYDRATE) RENAUDIN 1 mg/ml, solution injectable
Tour Hekla
Evaluation of the CKD-Epi score to identify a glomerular filtration threshold predictive of morphine failure at usual dosage, using a reference method for assessing renal function: iohexol clearance. All other aspects of the protocol are part of standard care practice.
1 trial -
Iomeron 400 mgI/ml solution for injection
The George Institute
Thoracic neoplasm
1 trial -
Irinotecan liposomes combined with cisplatin/carboplatin
The First People's Hospital of Lianyungang
Neuroendocrine Tumors
1 trial -
Isoniazid Aminosalicylate Tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Reinfection Pulmonary Tuberculosis
1 trial -
Ivabradine + Usual Care
The University of Hong Kong
Atrial Fibrillation (Permanent)
1 trial -
Ixazomib
Takeda
Relapsed and/or Refractory Multiple Myeloma
4 trials -
Ixekizumab
Hospital Authority, Hong Kong
Plaque Psoriasis
1 trial -
JZP-258
Jazz Pharmaceuticals Ireland Limited
Narcolepsy
1 trial -
JZP258
Jazz Pharmaceuticals Ireland Limited
Narcolepsy
1 trial -
JZP258 (XYWAV)
Jazz Pharmaceuticals Ireland Limited
Idiopathic Hypersomnia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources